Grounds crew workers Jacob Weiderstrom, left, and Marcus Gignac pull a tarp off home plate as they continue to keep the Seattle Mariners' field in playing shape as the ballpark goes into its seventh week without baseball played because of the coronavirus outbreak Monday, May 11, 2020, in Seattle. (AP Photo/Elaine Thompson)
By Ronald Blum
The baseball players' association gave management a wide-ranging response Thursday to a 67-page proposed set of protocols for a season to be played during the coronavirus pandemic.
Management had presented the union and the 30 teams the proposed draft last Friday.
The union said Thursday it addressed: protections for high-risk players, access to pre- and postgame therapies, testing frequency, protocols for positive tests, in-stadium medical personnel, and sanitization procedures.
Players viewed many of the concepts in the original draft as over-the-top, such as arriving in uniform at the ballparks, a prohibition on them leaving hotels without team permission, and a ban on guests other than immediate family members. Players also objected to a ban on the use of showers and hydrotherapy.
The union wants more frequent testing than management's proposed “multiple times per week.”
MLB is expected to make an economic proposal to the union within a few days. MLB hopes to start the season by early July.
The health and wellness industry is booming, expected to hit $14 trillion by 2032. Equinox teamed up with Function Health to revolutionize health optimization.
Featherie, a line of sustainable and functional golf wear for girls, fills a void in the market, catering to the increasing number of female junior golfers.
The CEO of LiveOne, Rob Ellin, discusses the DOJ's lawsuit against Live Nation and Ticketmaster, how will if affect you and the future of live events. Watch!
Nvidia did a record $26 billion in sales in the latest quarter. And get ready for the stock to keep climbing, because the A.I. boom is just getting started.
In honor of National Cancer Research Month, Perspective Therapeutics discusses its latest treatment — currently in clinical trials — that targets cancer cells d
